Skip to content
Therapy But Better – Lifestyle
Author:
ASTELLAS US LLC
Astellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026
May 18, 2026
IZERVAY® (avacincaptad pegol intravitreal solution) Demonstrated Increased Probability of Maintaining Driving Eligibility in Geographic Atrophy Patients
May 12, 2026
Astellas to Highlight New Findings for Geographic Atrophy at ARVO 2026 Annual Meeting
April 30, 2026
U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
April 20, 2026